China’s Yabao and Lawson complete discovery validation work of annexin A5-based products
The companies entered into an exclusive license in July 2014 to discover, develop and commercialize these products for the treatment of sepsis. Yabao Pharmaceutical R&D president Dr Peng
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.